American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone …

…, EP Mamounas, LJ Goldstein, TJ Whelan… - Journal of clinical …, 2005 - ascopubs.org
Purpose To update the 2003 American Society of Clinical Oncology technology assessment
on adjuvant use of aromatase inhibitors. Recommendations Based on results from multiple …

[HTML][HTML] Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

…, Y Wang, Z Wang, X Wang, T Whelan… - The Lancet …, 2018 - thelancet.com
… The trend test statistic (ie, the change from one stratum to the next in the log of the event
RR) is then T/var(T), which has variance 1/var(T). Tests of whether two trends are the same …

What do we mean by partnership in making decisions about treatment?

C Charles, T Whelan, A Gafni - Bmj, 1999 - bmj.com
For many decades, the dominant approach to making decisions about treatment in the
medical encounter has been one of paternalism. 1–7 In recent years this model has been …

Decision-making in the physician–patient encounter: revisiting the shared treatment decision-making model

C Charles, A Gafni, T Whelan - Social science & medicine, 1999 - Elsevier
In this paper we revisit and add elements to our earlier conceptual framework on shared
treatment decision-making within the context of different decision-making approaches in the …

[HTML][HTML] Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast …

…, G Viale, G von Minckwitz, T Watanabe, T Whelan… - Annals of oncology, 2015 - Elsevier
… They would not add such treatment based on T size; lymphovascular invasion; or the
involvement of one to three lymph nodes in such patients. However, the Panel almost unanimously …

[HTML][HTML] Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient …

…, R Gray, G Mannu, R Peto, T Whelan… - Database of Abstracts …, 2014 - ncbi.nlm.nih.gov
This review found that after mastectomy and axillary dissection, radiotherapy reduced both
recurrence and breast cancer mortality in women with one to three positive lymph nodes, …

Shared decision-making in the medical encounter: what does it mean?(or it takes at least two to tango)

C Charles, A Gafni, T Whelan - Social science & medicine, 1997 - Elsevier
Shared decision-making is increasingly advocated as an ideal model of treatment decision-making
in the medical encounter. To date, the concept has been rather poorly and loosely …

[HTML][HTML] Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer

…, TJ Saphner, LI Wagner, TJ Whelan… - … England Journal of …, 2018 - Mass Medical Soc
Background The recurrence score based on the 21-gene breast cancer assay predicts
chemotherapy benefit if it is high and a low risk of recurrence in the absence of chemotherapy if it …

[HTML][HTML] Prospective validation of a 21-gene expression assay in breast cancer

…, TJ Saphner, LI Wagner, TJ Whelan… - … England Journal of …, 2015 - Mass Medical Soc
Background Prior studies with the use of a prospective–retrospective design including
archival tumor samples have shown that gene-expression assays provide clinically useful …

[HTML][HTML] Long-term results of hypofractionated radiation therapy for breast cancer

TJ Whelan, JP Pignol, MN Levine… - … England Journal of …, 2010 - Mass Medical Soc
Background The optimal fractionation schedule for whole-breast irradiation after breast-conserving
surgery is unknown. Methods We conducted a study to determine whether a …